Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. CRISPR Therapeutics AG ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $51.81, marking a -3.5% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.3% for the ...

VedaBio has entered into agreement with Mammoth Biosciences to enhance its CRISPR-based molecular detection platform for ...

A study, published in the journal Frontiers in Genome Editing, outlines a method for editing single plant cells from sterile ...

This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading the developmental race).

The new system developed by Professor Chad Mirkin delivers CRISPR machinery more safely and effectively into cells.

It has long been understood that orchard automation is the key for industry’s profitability and sustainability. As part of ...

Researchers have unveiled a new type of nanostructure that dramatically improves CRISPR delivery. Called lipid nanoparticle ...

Thanks to CRISPR, our medical specialists will soon have unprecedented control over how they treat and prevent some of our most challenging genetic disorders and diseases. CRISPR (Clustered Regularly ...

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...